Product Description
An antidiabetic agent. A potent inhibitor of dipeptidyl peptidase IV (DPP IV), an enzyme that breaks down Glucagon-like peptide 1 (GLP-1). By delaying the degradation of GLP-1, vildagliptin extends the action of insulin while also suppressing the release of glucagon. This leads to a reduction in elevated blood glucose levels (hyperglycemia), which is a characteristic feature of type 2 diabetes.
Vildagliptin is an antidiabetic agent and a potent inhibitor of dipeptidyl peptidase IV (DPP IV), an enzyme that breaks down Glucagon-like peptide 1 (GLP-1).
Biovision | 2188 | Vildagliptin DataSheet
Alternate Name/Synonyms: (S)-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrrolidine-2-carbonitrile
Appearance: White to off-white solid
Formulation: N/A
CAS Number: 274901-16-5
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₇H₂₅N₃O₂
Molecular Weight: 303.4
Cell-Permeable?: Yes
Purity: ≥98%
Solubilities: DMSO or H₂O
Handling: Protect from air and moisture
Country of Origin: USA
Tag Line: A potent DPP IV Inhibitor,
MDL Number: MFCD08275142
PubChem CID: 6918537
SMILES: C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N
InChi: InChI=1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2/t12?,13?,14-,16?,17?/m0/s1
InChi Key: SYOKIDBDQMKNDQ-XWTIBIIYSA-N